These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 11318969

  • 1. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.
    Handelman GJ, Walter MF, Adhikarla R, Gross J, Dallal GE, Levin NW, Blumberg JB.
    Kidney Int; 2001 May; 59(5):1960-6. PubMed ID: 11318969
    [Abstract] [Full Text] [Related]

  • 2. Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.
    Ferraro B, Galli F, Frei B, Kingdon E, Canestrari F, Rice-Evans C, Buoncristiani U, Davenport A, Moore KP.
    Kidney Int; 2003 Jun; 63(6):2207-13. PubMed ID: 12753309
    [Abstract] [Full Text] [Related]

  • 3. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM, Jung BH, Paeng KJ, Kim SW, Chung BC.
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [Abstract] [Full Text] [Related]

  • 4. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.
    Lim PS, Chang YM, Thien LM, Wang NP, Yang CC, Chen TT, Hsu WM.
    Blood Purif; 2002 May; 20(6):537-42. PubMed ID: 12566669
    [Abstract] [Full Text] [Related]

  • 5. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
    Rivara MB, Ikizler TA, Ellis CD, Mehrotra R, Himmelfarb J.
    BMC Nephrol; 2015 Jun 05; 16():79. PubMed ID: 26045064
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure.
    Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W.
    Biofactors; 2005 Jun 05; 24(1-4):201-8. PubMed ID: 16403981
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G.
    J Ren Nutr; 2007 Sep 05; 17(5):296-304. PubMed ID: 17720098
    [Abstract] [Full Text] [Related]

  • 10. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L, Kalousová M, Soukupová J, Sulková S, Merta M, Jelínková E, Horejsí M, Srámek P, Malbohan I, Mikulíková L, Tesar V, Zima T.
    Kidney Blood Press Res; 2004 Sep 05; 27(2):88-95. PubMed ID: 14739577
    [Abstract] [Full Text] [Related]

  • 11. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA, Croft KD, Puddey IB, Beilin LJ.
    Anal Biochem; 1999 Mar 01; 268(1):117-25. PubMed ID: 10036170
    [Abstract] [Full Text] [Related]

  • 12. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr 01; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 13. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
    Boaz M, Iuliano L, Himmelfarb J, Matas Z, Micheletta F, McMonagle E, Friedman V, Natoli S, Gvirtz G, Biro A, Smetana S, Sabo G, Gafter U, Weinstein T.
    Nephron Clin Pract; 2005 Apr 01; 100(4):c111-9. PubMed ID: 15849477
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C, Naruko T, Sugioka K, Yunoki K, Nakagawa M, Inaba M, Ohsawa M, Konishi Y, Imanishi M, Inoue T, Itabe H, Yoshiyama M, Haze K, Becker AE, Ueda M.
    Hemodial Int; 2013 Oct 01; 17(4):557-67. PubMed ID: 23627905
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
    Montazerifar F, Hashemi M, Karajibani M, Dikshit M.
    J Med Food; 2010 Dec 01; 13(6):1490-3. PubMed ID: 21091256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.